Skip to content

Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD

Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01060553
Enrollment
34
Registered
2010-02-02
Start date
2010-07-31
Completion date
2011-12-31
Last updated
2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic Stress Disorders

Keywords

Post-traumatic stress disorders, Acupuncture, Quality of life, sleep disorder

Brief summary

The purpose of this study is to examine if acupuncture improves Post-Traumatic Stress Disorder symptoms among veterans who participated in Operations Enduring Freedom and Iraqi Freedom. This study will also examine the degree of veteran acceptance for acupuncture.

Detailed description

Project Background: Acupuncture can be effective for many of the specific co-morbidities that make up war-related Trauma Spectrum Disorder in both TBI and PTSD patients, including pain, stress and anxiety, insomnia, somatic and post-operative pain. Recent studies find very large effect sizes (Cohen's D .85 to 1.4). Thus, there is good reason to believe that acupuncture will induce recovery across a number of trauma spectrum dysfunctions in patients with TBI and PTSD, at low cost and with little risk. Project Objectives: The overall objective of this application is to determine the efficacy of adjunctive acupuncture for improving quality of life and function and alleviating co-morbidities associated with TBI and PTSD in service members injured in the current wars. The primary hypothesis of this study is: OIF/OEF veterans who screen positive for TBI or PTSD and are treated with a 12 week standard individualized acupuncture method will experience improved HRQL (as measured by the Veteran's SF-36) at 6, 12 and 24 week follow-up, compared to veterans randomly assigned to standard care alone. Project Methods: This is a pilot study on veterans who screen positive for TBI or PTSD in the VA healthcare record, which is being submitted to obtain additional pilot data, confirmation of recruitment strategies, and information on non-participants . Frequency distribution and summary statistics for demographics and baseline variables will be presented by intervention group and for all subjects combined. Key demographic variables to be summarized are: age, gender, time to deployment, number of deployments, and diagnosis. Key baseline variables are: PTSD CAPS score, VSF-36, and ANAM score.

Interventions

OTHERAcupuncture treatment

This project was initially designed as a randomized trial with one group receiving treatment and the other wait list control, with delayed treatment. Due to extremely high dropout and cancellations and failure to return for post assessment, a midpoint assessment was added. Analysis was done on pre and post measures of all subjects who completed at least the midpoint assessment. Due to the very small number of subjects in the wait list control, the ones who completed 6 or 12 weeks of acupuncture after the wait list were combined with the few who completed the initial acupuncture for a pre-post single group analysis. for those who completed both the 6 and 12 week measures, the latest one was selected for analysis

Sponsors

Samueli Institute for Information Biology
CollaboratorOTHER
US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis or positive screen test for PTSD. * Combat veterans of Operation Iraqi Freedom or Operation Enduring Freedom conflicts.

Exclusion criteria

* Unable to travel to East Orange VA for 12 consecutive weeks, biweekly for treatment. * Does not speak English. * Acupuncture or CBT treatment within the previous six months.

Design outcomes

Primary

MeasureTime frameDescription
SF-36baseline, 6 or 12 weeks (latest available is used)global health functioning Mental component (MCS) and Physical component (PCS) subscales range from 0 to 100 with 100 being better; 50 is expected population average.

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Indexbaseline, 6 or 12 weeks (latest available is used)subscales range from 0 to 3 with higher being worse.

Countries

United States

Participant flow

Pre-assignment details

34 subjects were interviewed for consent. 15 were assigned to immediate treatment. 15 were assigned to wait list treatment. 2 did not meet inclusion criteria. 2 were assigned to case study.

Participants by arm

ArmCount
Arm 1
24 semi-individualized acupuncture treatments over 12 weeks. The front treat-ment uses 11 needles, bilateral at acupuncture points LR3, PC6, HT7, ST36, SP6, and one at Yintang; the back treatment uses 14 needles, bilateral at points GB20, and BL14, 15, 18, 20, 21, and 23. There are 15 other points from which the flexibly prescribed points could be chosen
30
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLack of Efficacy10
Overall StudyLost to Follow-up35
Overall StudyWithdrawal by Subject55

Baseline characteristics

CharacteristicArm 1
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

SF-36

global health functioning Mental component (MCS) and Physical component (PCS) subscales range from 0 to 100 with 100 being better; 50 is expected population average.

Time frame: baseline, 6 or 12 weeks (latest available is used)

Population: due to very small numbers of completers in the acupuncture and the wait list control, the data from the wait list group who completed at least 6 weeks of treatment were combined with those initially assigned to treatment for a single group pre/post analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Arm 1SF-36mcs pre treatment35.2 units on a scaleStandard Deviation 10.7
Arm 1SF-36mcs post treatment39.0 units on a scaleStandard Deviation 12.6
Arm 1SF-36pcs pre treatment41.2 units on a scaleStandard Deviation 9.9
Arm 1SF-36pcs post treatment44.5 units on a scaleStandard Deviation 9.5
Comparison: for mcsp-value: 0.15t-test, 2 sided
Comparison: for pcsp-value: 0.28t-test, 2 sided
Secondary

Pittsburgh Sleep Index

subscales range from 0 to 3 with higher being worse.

Time frame: baseline, 6 or 12 weeks (latest available is used)

Population: due to very small numbers of completers in the acupuncture and the wait list control, the data from the wait list group who completed at least 6 weeks of treatment were combined with those initially assigned to treatment for a single group pre/post analysis

ArmMeasureGroupValue (MEAN)Dispersion
Arm 1Pittsburgh Sleep Indexsleep duration pre2.4 units on a scaleStandard Deviation 0.7
Arm 1Pittsburgh Sleep Indexsleep duration post2.1 units on a scaleStandard Deviation 0.7
Arm 1Pittsburgh Sleep Indexsleep disturbance pre2.4 units on a scaleStandard Deviation 0.5
Arm 1Pittsburgh Sleep Indexsleep distubance post1.7 units on a scaleStandard Deviation 0.7
Arm 1Pittsburgh Sleep Indexsleep latency pre2.6 units on a scaleStandard Deviation 0.5
Arm 1Pittsburgh Sleep Indexsleep latency post1.7 units on a scaleStandard Deviation 1.2
Comparison: for sleep durationp-value: 0.34t-test, 2 sided
Comparison: for sleep disturbancep-value: 0.001t-test, 2 sided
Comparison: for sleep latencyp-value: 0.015t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026